Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Respiratory drugs in Fujisawa's product pipeline

Oct. 11, 1996

Respiratory R&D at Yamanouchi

Oct. 11, 1996

Approval of Pulmozyme recommended for new indication

Oct. 11, 1996

Treatment for cystic fibrosis patients progresses on schedule

Oct. 11, 1996

Dual thromboxane synthase/lipoxygenase inhibitors from Nikken Chemicals

Oct. 11, 1996

New antihistamine for pediatric patients in the U.S.

Oct. 11, 1996

HLE inhibitors described by Zeneca

Oct. 4, 1996

Medeva terminates agreement with Chiesi related to dry powder inhaler

Oct. 4, 1996

Spotlight on LTD4 antagonists

Oct. 4, 1996

Axiom-Zaiya CD40 research collaboration

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...